Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Airway epithelial SPDEF integrates goblet cell differentiation and pulmonary Th2 inflammation
Priya Rajavelu, … , Thomas R. Korfhagen, Jeffrey A. Whitsett
Priya Rajavelu, … , Thomas R. Korfhagen, Jeffrey A. Whitsett
Published April 13, 2015
Citation Information: J Clin Invest. 2015;125(5):2021-2031. https://doi.org/10.1172/JCI79422.
View: Text | PDF
Research Article Pulmonology

Airway epithelial SPDEF integrates goblet cell differentiation and pulmonary Th2 inflammation

  • Text
  • PDF
Abstract

Epithelial cells that line the conducting airways provide the initial barrier and innate immune responses to the abundant particles, microbes, and allergens that are inhaled throughout life. The transcription factors SPDEF and FOXA3 are both selectively expressed in epithelial cells lining the conducting airways, where they regulate goblet cell differentiation and mucus production. Moreover, these transcription factors are upregulated in chronic lung disorders, including asthma. Here, we show that expression of SPDEF or FOXA3 in airway epithelial cells in neonatal mice caused goblet cell differentiation, spontaneous eosinophilic inflammation, and airway hyperresponsiveness to methacholine. SPDEF expression promoted DC recruitment and activation in association with induction of Il33, Csf2, thymic stromal lymphopoietin (Tslp), and Ccl20 transcripts. Increased Il4, Il13, Ccl17, and Il25 expression was accompanied by recruitment of Th2 lymphocytes, group 2 innate lymphoid cells, and eosinophils to the lung. SPDEF was required for goblet cell differentiation and pulmonary Th2 inflammation in response to house dust mite (HDM) extract, as both were decreased in neonatal and adult Spdef–/– mice compared with control animals. Together, our results indicate that SPDEF causes goblet cell differentiation and Th2 inflammation during postnatal development and is required for goblet cell metaplasia and normal Th2 inflammatory responses to HDM aeroallergen.

Authors

Priya Rajavelu, Gang Chen, Yan Xu, Joseph A. Kitzmiller, Thomas R. Korfhagen, Jeffrey A. Whitsett

×

Figure 4

SPDEF is required for AHR, Th2, and TH17 inflammatory responses to HDM in postnatal mice.

Options: View larger image (or click on image) Download as PowerPoint
SPDEF is required for AHR, Th2, and TH17  inflammatory responses to HDM ...
HDM (50 μg) was administered i.n. daily for 3 days to PND15 control and Spdef–/– mice, and the mice were sacrificed 2 days later. (A) Decreased mucous metaplasia and inflammatory responses to HDM were observed in Spdef–/– mice. (A and C) BALF cells (n = 4) were stained with Diff-Quik, demonstrating eosinophilic and neutrophilic infiltrates. Goblet cell differentiation (A) and increased Acta2 mRNA caused by HDM challenge (Table 4) were modestly decreased in Spdef–/– mice. (B) Spdef–/– mice were less responsive to HDM (green) than were controls (red line). Data represent the mean ± SEM, using 2-way Anova with Bonferroni’s post tests. n = 6/group. (D and E) Flow analysis of lung cells from Spdef+/+ (white bars) and Spdef–/– mice (black bars) after HDM challenge. SiglecF+CCR3+ eosinophils were decreased, and ST2+, IL-17RB+, ICOS+ ILCs and CD3+ cells were unaltered. CD3+ IL-4+ and CD3+IL-17+ T cells were decreased in Spdef–/– mice, and CD3+IFN-γ+ T cells were unaltered. Gating strategies are depicted in Supplemental Figure 1. Data represent the mean ± SEM. *P < 0.05 compared with controls using an unpaired, 2-tailed Student’s t test. n = 4/group.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts